Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.31 - $11.18 $38,743 - $59,254
5,300 Added 126.19%
9,500 $71,000
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $39,816 - $60,984
4,200 New
4,200 $42,000
Q4 2021

Jan 25, 2022

SELL
$12.99 - $17.73 $229,923 - $313,821
-17,700 Closed
0 $0
Q3 2021

Oct 19, 2021

BUY
$14.85 - $21.34 $262,845 - $377,718
17,700 New
17,700 $270,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.